Ironwood Pharmaceuticals | IRWD - Ordinary Share Capital


Ironwood Pharmaceuticals reported $160K in Ordinary Share Capital for its fiscal quarter ending in December of 2024.





Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 169.18M 470K Dec/2025
Agios Pharmaceuticals USD 59.34M 892K Mar/2026
Akebia Therapeutics USD 265.42M 199K Dec/2025
Almirall EUR 214.79M 0 Dec/2025
Alnylam Pharmaceuticals USD 133.44M 1.07M Mar/2026
Amarin USD 20.81M 13K Dec/2025
Ardelyx USD 244.35M 1.38M Dec/2025
Astellas Pharma JPY 1.79B 81K Mar/2026
AstraZeneca USD 1.55B 73K Mar/2026
Charles River Laboratories USD 48.17M 1.05M Mar/2026
Coherus Biosciences USD 121.16M 4.92M Dec/2025
Emergent BioSolutions USD 100K 0 Jun/2023
Esperion Therapeutics USD 245.22M 39.79M Dec/2025
Halozyme Therapeutics USD 118.52M 741K Mar/2026
Incyte USD 199.95M 1.49M Mar/2026
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
Karyopharm Therapeutics USD 18.31M 18.3M Dec/2025
Lexicon Pharmaceuticals USD 363.47M 67K Dec/2025
MacroGenics USD 63.32M 60K Dec/2025
Moderna USD 391M 2M Sep/2025
Myriad Genetics USD 93.5M 400K Dec/2025
Pacira USD 39.31M 1.81M Mar/2026
PTC Therapeutics USD 81.47M 1.54M Dec/2025
Puma Biotechnology USD 5K 0 Jun/2024
Sarepta Therapeutics USD 105.57M 607K Mar/2026
Takeda JPY 1.58B 241K Mar/2026
Ultragenyx Pharmaceutical USD 98.3M 1.7M Mar/2026
Vanda Pharmaceuticals USD 58K 0 Dec/2024